Doctors have a new weapon in the fight against particularly pernicious depression: a drug based on the powerful anesthetic ketamine. The drug — called Spravato and developed by Janssen Pharmaceuticals, Inc. — was approved on March 5 by the U.S. ...

Read full story >>